Close Menu

chlamydia

NEW YORK (GenomeWeb News) – A Leerink Swann survey of diagnostic laboratories in Europe found that molecular-based testing continues to find traction with continued penetration strongest in methicillin-resistant Staphylococcus aureus testing and human papillomavirus testing.

Researchers from Children's Hospital Oakland Research Institute, Emory University, and Network Biosystems have been awarded a five-year grant from the National Institutes of Health to develop an assay for NetBio's integrated molecular testing system that will identify the biothre

NEW YORK (GenomeWeb News) – Once the $3.7 billion Hologic acquisition of Gen-Probe is completed, Gen-Probe will become the "hub" of Hologic's diagnostics business, and in addition to selling the San Diego company's

NEW YORK (GenomeWeb News) – Cepheid this week updated its test pipeline with a focus on gonorrhea and chlamydia, cancer, and tuberculosis over the next few years.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Gen-Probe's Panther, a fully automated and integrated molecular testing platform, the San Diego-based company announced today.

Hologic's planned $3.7 billion acquisition of Gen-Probe, announced earlier this week, is expected to create the largest diagnostics company focused on women's health, according to Hologic officials.

By Ben Butkus
Gen-Probe this week reported record revenues of $158.2 million in the fourth quarter of 2011, driven primarily by sales of clinical diagnostics and blood screening products.

Pages

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.